Circulating Microparticles Alter Formation, Structure, and Properties of Fibrin Clots

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Zubairova, Laily D ^a   Nabiullina, Roza M ^a   Nagaswami, Chandrasekaran ^b   Zuev, Yuriy F ^c   Mustafin, Ilshat G ^a   Litvinov, Rustem I ^b,d   Weisel, John W ^b  

^a KAZAN STATE MEDICAL UNIVERSITY   (Russian Federation)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c KAZAN INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Russian Federation)

^d KAZAN FEDERAL UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; THROMBIN;

ADULT; BLOOD; BLOOD CLOTTING; CHEMISTRY; FEMALE; FIBRINOLYSIS; FLOW CYTOMETRY; HUMAN; MALE; MEMBRANE MICROPARTICLE; METABOLISM; PATHOLOGY; THROMBOCYTE; THROMBOSIS; ULTRASTRUCTURE;

ADULT; BLOOD COAGULATION; BLOOD PLATELETS; CELL-DERIVED MICROPARTICLES; FEMALE; FIBRIN; FIBRINOLYSIS; FLOW CYTOMETRY; HUMANS; MALE; THROMBIN; THROMBOSIS;

EID: 84949239275     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep17611     Document Type: Article

References (60)

1. Lacroix, R. et al. Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. Journal of Thrombosis and Haemostasis, 8, 2571-2574 (2010).
2. Morel, O., Jesel, L., Freyssinet, J-M. & Toti, F. Cellular mechanisms underlying the formation of circulating microparticles. Arteriosclerosis Thrombosis and Vascular Biology, 31, 15-26 (2011).
3. Lacroix, R., Dubois, C., Leroyer, A.S., Sabatier, F. & Dignat-George, F. Revisited role of microparticles in arterial and venous thrombosis. Journal of Thrombosis and Haemostasis, 11, 24-35 (2013).
4. Hrachovinova, I. et al. Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. Nature Medicine, 9, 1020-1025 (2003).
5. Furie, B. & Furie, B. C. Thrombus formation in vivo. The Journal of Clinical Investigations, 115, 3355-3362 (2005).
6. Aras, O. et al. Induction of microparticle-and cell-associated intravascular tissue factor in human endotoxemia. Blood, 103, 4545-4553 (2004).
7. Khorana, A. A. et al. Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. Journal of Thrombosis and Haemostasis, 6, 1983-1985 (2008).
8. Tesselaar, M. E. et al. Microparticle-associated tissue factor activity: a link between cancer and thrombosis? Journal of Thrombosis and Haemostasis, 5, 520-527 (2007).
9. Van Der Meijden, P.E. et al. Platelet-and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa. Journal of Thrombosis and Haemostasis, 10, 1355-1362 (2012).
10. Owens, A. P. & Mackman, N. Microparticles in hemostasis and thrombosis. Circulation Research, 108, 1284-1297 (2011).
11. Vasina, E., Heemskerk, J. W., Weber, C. & Koenen, R. R. Platelets and platelet-derived microparticles in vascular inflammatory disease. Inflammation and Allergy-Drug Targets, 9, 346-354 (2010).
12. Cui, Y. et al. Circulating microparticles in patients with coronary heart disease and its correlation with interleukin-6 and C-reactive protein. Molecular Biology Reports, 40, 6437-6442 (2013).
13. Boisramé-Helms, J. et al. Pharmacological modulation of procoagulant microparticles improves haemodynamic dysfunction during septic shock in rats. Thrombosis and Haemostasis, 111, 154-164 (2014).
14. Marchetti, M. et al. Phospholipid-dependent procoagulant activity is highly expressed by circulating microparticles in patients with essential thrombocythemia. American Journal of Hematology, 89, 68-73 (2014).
15. Chaturvedi, S. et al. Circulating microparticles in patients with antiphospholipid antibodies: Characterization and associations. Thrombosis Research, 135, 102-108 (2015).
16. Rodriguez-Carrio, J. et al. Altered profile of circulating microparticles in rheumatoid arthritis patients. Clinical Science, 128, 437-448 (2015).
17. Jimenez, J. J. et al. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thrombosis Research, 109, 175-180 (2003).
18. Perez-Pujol, S., Marker, P. H. & Key, N. S. Platelet microparticles are heterogeneous and highly dependent on the activation mechanism: studies using a new digital flow cytometer. Cytometry Part A, 71, 38-45 (2007).
19. Aleman, M. M., Gardiner, C., Harrison, P. & Wolberg, A. S. Differential contributions of monocyte-and platelet-derived microparticles towards thrombin generation and fibrin formation and stability. Journal of Thrombosis and Haemostasis, 9, 2251-2261 (2011).
20. Horstman, L. L. & Ahn, Y. S. Platelet microparticles: a wide-angle perspective. Critical Reviews in Oncology/Hematology, 30, 111-142 (1999).
21. Flaumenhaft, R. et al. Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles. Blood, 113, 1112-11121 (2009).
22. Cauwenberghs, S. et al. Shedding of procoagulant microparticles from unstimulated platelets by integrin-mediated destabilization of actin cytoskeleton. FEBS Letters, 580, 5313-5320 (2006).
23. Berckmans, R. J. et al. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thrombosis and Haemostasis, 85, 639-646 (2001).
24. Bridge, K. I., Philippou, H. & Ariens, R. Clot properties and cardiovascular disease. Thrombosis and Haemostasis, 112, 1-8 (2014).
25. Collet, J. P., Montalescot, G., Lesty, C. & Weisel, J. W. A structural and dynamic investigation of the facilitating effect of glycoportein IIb/IIIa inhibitors in dissolving platelet-rich clots. Circulation Research, 90, 428-434 (2002).
26. Weisel, J. W. Structure of fibrin: impact on clot stability. Journal of Thrombosis and Haemostasis, 5, 116-124 (2007).
27. Weisel, J. W. & Litvinov, R. I. Mechanisms of fibrin polymerization and clinical implications. Blood, 121, 1712-1719 (2013).
28. Tehrani, S. et al. Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia. Thrombosis Research, 126, 225-231 (2010).
29. Cunningham, M. T., Citron, B. A. & Koerner, T. A. Evidence of a phospholipid binding species within human fibrinogen preparations. Thrombosis Research, 95, 325-334 (1999).
30. Siljander, P., Carpen, O. & Lassila, R. Platelet-derived microparticles associate with fibrin during thrombosis. Blood, 87, 4651-4663 (1996).
31. Stepien, E., Konkolewska, M., Kapusta, M. & Zurakowski, A. Correlation between the number and origin of circulating microparticles and fibrin clot properties in patients with coronary artery disease. International Journal of Cardiology, 181, 147-148 (2015).
32. Morel, O., Morel, N., Jesel, L., Freyssinet, J-M. & Toti, F. Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis. Seminars in Immunopathology, 33, 469-486 (2011).
33. Zwicker, J. I., Trenor, C. C., Furie, B. C. & Furie, B. Tissue factor-bearing microparticles and thrombus formation. Arteriosclerosis Thrombosis and Vascular Biology, 31, 728-733 (2011).
34. Zwicker, J. I., Lacroix, R., Dignat-George, F., Furie, B. C. & Furie, B. Measurement of platelet microparticles. Methods in Molecular Biology, 788, 127-139 (2012).
35. Lacroix, R., Dubois, C., Leroyer, A. S., Sabatier, F. & Dignat-George, F. Revisited role of microparticles in arterial and venous thrombosis. Journal of Thrombosis and Haemostasis, 11, 24-35 (2013).
36. Furie, B. & Furie, B. C. Cancer-associated thrombosis. Blood Cells, Molecules and Diseases, 36, 177-181 (2006).
37. Yuana, Y. et al. Atomic force microscopy: a novel approach to the detection of nanosized blood microparticles. Journal of Thrombosis and Haemostasis, 8, 315-323 (2010).
38. Granta, R. et al. A filtration-based protocol to isolate human plasma membrane-derived vesicles and exosomes from blood plasma. Journal of Immunological Methods, 371, 143-151 (2011).
39. Rousseau, M. et al. Detection and quantification of microparticles from different cellular lineages using flow cytometry. Evaluation of the impact of secreted phospholipase A2 on microparticle assessment. PLoS One, 10, e0116812 (2015).
40. Chou, M. L., Lin, L. T., Devos, D. & Burnouf, T. Nanofiltration to remove microparticles and decrease the thrombogenicity of plasma: in vitro feasibility assessment. Transfusion, 2015 May 18. doi: 10.1111/trf.13162. [Epub ahead of print].
41. Ollivier, V. et al. Detection of endogenous tissue factor levels in plasma using the calibrated automated thrombogram assay. Thrombosis Research, 125, 90-96 (2010).
42. Weisel, J. W. & Nagaswam,i C. Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled. Biophysical Journal, 63, 111-128 (1992).
43. Collet, J. P., Lesty, C., Montalescot, G. & Weisel, J. W. Dynamic changes of fibrin architecture during fibrin formation and intrinsic fibrinolysis of fibrin-rich clots. The Journal of Biological Chemistry, 278, 21331-21335 (2003).
44. Longstaff, C. et al. The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies. Blood, 117, 661-668 (2011).
45. Bannish, B. E., Keener, J. P., Woodbury, M., Weisel J. W. & Fogelson, A. L. Modelling fibrinolysis: 1D continuum models. Mathematical Medicine and Biology, 31, 45-64 (2014).
46. Bannish, B. E., Keener, J. P. & Fogelson, A. L. Modelling fibrinolysis: a 3D stochastic multiscale model. Mathematical Medicine and Biology, 31, 17-44 (2014).
47. Soeda, S., Kakiki, M., Shimeno, H. & Nagamatsu, A. Some properties of tissue-type plasminogen activator reconstituted onto phospholipid and/or glycolipid vesicles. Biochemical and Biophysical Research Communications, 146, 94-100 (1987).
48. Gunter, A., Kalinowski, M., Rosseau, S. & Seeger, W. Surfactant incorporation markedly alters mechanical properties of a fibrin clot. American Journal of Respiratory Cell and Molecular Biology, 13, 712-718 (1995).
49. Varadi, B. et al. Phospholipid barrier to fibrinolysis: role for the anionic polar head charge and the gel-phase crystalline structure. Journal of Biological Chemistry, 279, 39863-39871 (2004).
50. Holme, P. A., Solum, N. O., Brosstad, F., Roger, M. & Abdelnoor, M. Demonstration of platelet-derived microvesicles in blood from patients with activated coagulation and fibrinolysis using a filtration technique and western blotting. Thrombosis and Haemostasis, 72, 666-671 (1994).
51. Doeuvre, L., Plawinski, L., Goux, D., Vivien, D. & Anglés-Cano, E. Plasmin on adherent cells: from microvesiculation to apoptosis. Biochemical Journal, 432, 365-373 (2010).
52. Peramo, A. & Diaz, J. A. Physical characterization of mouse deep vein thrombosis derived microparticles by differential filtration with nanopore filters. Membranes, 2, 1-15 (2012).
53. Surewicz, W. K., Epand, R. M., Pownall, H. J. & Hui, S. W. Human apolipoprotein A-I forms thermally stable complexes with anionic but not with zwitterionic phospholipids. Journal of Biological Chemistry, 261, 16191-16197 (1986).
54. Litvinov, R. I., Shuman, H., Bennett J. S. & Weisel, J. W. Binding strength and activation state of single fibrinogen-integrin pairs on living cells. Proceedings of the National Academy of Sciences of the USA, 99, 4426-4431 (2002).
55. Carvalho, F. A. et al. Atomic force microscopy-based molecular recognition of a fibrinogen receptor on human erythrocytes. ACS Nano, 4, 4609-4620 (2010).
56. Iversen, L. V., Ostergaard, O., Nielsen, C. T., Jacobsen, S. & Heegaard, N. H. A heparin-based method for flow cytometric analysis of microparticles directly from platelet-poor plasma in calcium containing buffer. Journal of Immunological Methods, 388, 49-59 (2013).
57. Gent, C. M. & Van, Roseleur, O. J. Quantitative determination of phospholipids in blood serum or plasma by a nondestructive method. Clinica Chimica Acta, 57, 197-203 (1974).
58. Hemker, H. C. et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiology of Haemostasis and Thrombosis, 33, 4-15 (2003).
59. Hemker, H. C., Al Dieri, R. A., De Smedt, E. D. & Béguin, S. Thrombin generation, a function test of the haemostatic-thrombotic system. Thrombosis and Haemostasis, 96, 553-561 (2006).
60. Brummel-Ziedins, K. E., Everse, S. J., Mann, K. G. & Orfeo, T. Modeling thrombin generation: plasma composition based approach. Journal of Thrombosis and Thrombolysis, 37, 32-44 (2014).